HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 247 filers reported holding HAEMONETICS CORP in Q4 2017. The put-call ratio across all filers is 1.58 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $2,105,000 | -57.0% | 36,246 | -66.7% | 0.03% | -62.1% |
| Q3 2017 | $4,890,000 | -29.9% | 108,976 | -38.3% | 0.09% | -41.6% |
| Q2 2017 | $6,979,000 | +18.4% | 176,719 | +21.6% | 0.15% | +14.6% |
| Q1 2017 | $5,895,000 | +995.7% | 145,318 | +984.5% | 0.13% | +712.5% |
| Q4 2016 | $538,000 | -3.6% | 13,400 | -13.1% | 0.02% | -23.8% |
| Q3 2016 | $558,000 | -62.9% | 15,419 | -70.3% | 0.02% | -74.1% |
| Q2 2016 | $1,503,000 | +491.7% | 51,853 | +614.6% | 0.08% | +406.2% |
| Q1 2016 | $254,000 | -74.5% | 7,256 | -76.5% | 0.02% | -79.2% |
| Q4 2015 | $995,000 | +141.5% | 30,860 | +142.1% | 0.08% | +18.5% |
| Q3 2015 | $412,000 | +6.2% | 12,747 | +36.0% | 0.06% | +333.3% |
| Q2 2015 | $388,000 | +36.6% | 9,376 | +48.2% | 0.02% | +36.4% |
| Q1 2015 | $284,000 | +35.9% | 6,327 | +13.1% | 0.01% | 0.0% |
| Q4 2014 | $209,000 | -16.7% | 5,596 | -22.1% | 0.01% | -42.1% |
| Q3 2014 | $251,000 | – | 7,188 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nitorum Capital, L.P. | 413,122 | $16,608,000 | 4.78% |
| Altalis Capital Management LLC | 88,055 | $3,540,000 | 3.97% |
| RUTABAGA CAPITAL MANAGEMENT LLC/MA | 513,619 | $20,647,000 | 3.54% |
| Black Creek Investment Management Inc. | 1,118,613 | $44,968,000 | 3.46% |
| HealthCor Management, L.P. | 1,150,000 | $46,230,000 | 2.61% |
| Van Berkom & Associates Inc. | 1,136,971 | $45,706,000 | 1.83% |
| AMERICAN CAPITAL MANAGEMENT INC | 567,896 | $22,829,000 | 1.77% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 2,062,539 | $82,914,000 | 1.25% |
| Legato Capital Management LLC | 1,336 | $53,707,000 | 0.97% |
| HEARTLAND ADVISORS INC | 351,314 | $14,123,000 | 0.78% |